A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

This study is testing GX-03, a topical (applied to the skin) treatment for moderate to severe eczema (atopic dermatitis). Researchers want to see if this product can reduce the severity and extent of eczema flares when applied daily to affected skin areas. **You may be eligible if:** - You are aged 18 to 70 years old - You have moderate to severe eczema confirmed by a doctor using standard assessments - You are generally healthy - You can read, understand, and provide written consent in English - You are willing to apply the study product daily to designated skin areas throughout the study **You may NOT be eligible if:** - You are pregnant, breastfeeding, or planning to become pregnant during the study - You have another skin condition that could interfere with the study assessments - You have used steroid creams, immune-suppressing medications, or anti-inflammatory drugs within the past 3 weeks - You have damaged, sunburned, tattooed, or scarred skin at the test sites - You have used any topical medication at the test site within 72 hours before enrolling - You have a medical condition that, in the investigator's judgment, puts you at risk Talk to your doctor to see if this trial is right for you.